Gilead Sciences to buy Cell Design Labs for $567 million
The company said it will acquire the 12.2% of Cell Design shares held by recently acquired Kite Pharma Inc. . The deal includes an upfront payment of about $175 million and additional milestone payments of up to $322 million to be paid to Cell Design Labs shareholders other than Kite, Gilead said.
from Biotech News
0 Comments